Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Arch Razi Inst ; 74(3): 267-277, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31592592

RESUMO

In order to evaluate the healing effect of eugenol and other nanofibers, 100 male Wistar rats (200±10 g) were used with 14-15 weeks of age in this study. All of the male rats were transferred in the standard cages under controlled exposure conditions in a 12:12 h light/dark cycle with a constant temperature about 22±2 oC. In addition, the male rats were fed with pellets. Firstly, anesthesia process was performed by 2% xylazine hydrochloride (10mg/Kg/IP) and 10% ketamine hydrochloride (100mg/Kg/IP), and then the rats were placed on the operating table. Then the dorsal surfaces of the rats’ skin to ileum were scrubbed and prepared as the next step. A circular wound (with a 7 mm diameter) was created by a 7 mm sterile biopsy punch. All 100 rats were divided into four groups (n=25) randomly named as control, nano zinc oxide (ZnO), eugenol nanofibers, and polycaprolactone groups. After that, they were divided into five groups regarding the wound closure rate in days 3, 5, 7, 14, and 21. Then, the wound dressings were placed on the wounds and renewed every 24 h. At the end of days 3, 5, 7, 14, and 21, the relevant tests, such as histopathology, were conducted by removing the tissue volume using a biopsy punch, and then decapitation process was performed on the rats. It was obvious that eugenol nanofiber showed the best granulation tissue by the production of collagen. Further studies are being performed on wound healing by eugenol nanofiber.


Assuntos
Eugenol , Nanofibras , Pele , Syzygium , Cicatrização , Óxido de Zinco , Animais , Masculino , Ratos , Bandagens , Eugenol/farmacologia , Tecido de Granulação/fisiologia , Extratos Vegetais/farmacologia , Poliésteres/farmacologia , Ratos Wistar , Pele/lesões , Syzygium/química , Cicatrização/fisiologia , Óxido de Zinco/farmacologia
2.
Arch Razi Inst ; 74(1): 69-75, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-31013008

RESUMO

Anesthesia and analgesia are important in human and veterinary medicine, especially in surgical procedures. Rodents, avians, and exotic species are required to be anesthetized using an appropriate anesthetic regimen. This study aimed to suggest a new anesthetic drug and method in order to facilitate anesthesia as well as analgesia among rabbits, laboratory animals, and humans. Spinal injection of dexamethasone combined with intramuscular ketamine among rabbits can play the role of premedication agents. A total of 24 healthy white adult rabbits from New-Zealand were equally assigned into four groups. Groups 1, 2, 3, and 4 were subjected to spinal xylazine (5mg/kg) with ketamine (35mg/kg,IM), spinal dexamethasone (0.37mg/kg-four times diluted) with ketamine (35mg/kg,IM), dexamethasone (4mg/kg,IM) with ketamine (35mg/kg,IM), and spinal dexamethasone (0.37mg/kg-four times diluted), respectively. The results showed that there was a significant difference in terms of clinical reflexes recorded for group 2, compared to groups 1 and 3. A significant difference was also observed regarding clinical reflexes between group 2 and the other groups. Furthermore, no abnormality was observed in terms of histological sections within groups 2 and 4. Spinal dexamethasone can be used as a premedication combined with ketamine in rabbit anesthesia.


Assuntos
Analgésicos/uso terapêutico , Anestésicos Combinados/uso terapêutico , Dexametasona/uso terapêutico , Ketamina/uso terapêutico , Pré-Medicação/veterinária , Animais , Hipnóticos e Sedativos/uso terapêutico , Injeções Espinhais/veterinária , Masculino , Fármacos Neuromusculares/uso terapêutico , Pré-Medicação/métodos , Coelhos , Xilazina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA